Delayed diagnosis of congenital thrombotic thrombocytopenic purpura in a patient with recurrent strokes

被引:4
作者
Beltrami-Moreira, Marina [1 ]
DeSancho, Maria T. [1 ]
机构
[1] Weill Cornell Med, New York Presbyterian Hosp, Dept Med, Div Hematol & Oncol, 1305 York Ave 7th Floor Room 51, New York, NY 10021 USA
关键词
Congenital thrombotic thrombocytopenia purpura; Cryptogenic recurrent strokes; ADAMTS13; ACTIVITY; WILLEBRAND;
D O I
10.1007/s11239-021-02629-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Congenital thrombotic thrombocytopenic purpura (cTTP) is caused by ADAMTS13 mutations and associated with high risk of microvascular thrombosis. A 58 year old female had an ischemic stroke during hormonal fertility, and a TIA a year after. She suffered another stroke 18 years later while on warfarin. Four months after she developed severe thrombocytopenia, mild anemia, and increased LDH. Blood film showed schistocytes. She was hospitalized with presumptive TTP. ADAMTS 13 activity was undetectable without inhibitor. She developed another stroke and received plasma exchange. A homozygote ADAMTS 13 mutation was identified. Despite plasma, the ADAMTS13 activity remained < 10% and she had another stroke. Recombinant ADAMTS13 therapy was obtained through compassionate use. She receives weekly infusions maintaining ADAMTS13 trough levels above 10% without thrombotic recurrences. This case underscores the need to recognize cTTP as a cause of cryptogenic strokes, and the diagnostic value of the peripheral blood film. rADAMTS13 replacement may prevent recurrences.
引用
收藏
页码:734 / 738
页数:5
相关论文
共 14 条
[1]   Characterization and treatment of congenital thrombotic thrombocytopenic purpura [J].
Alwan, Ferras ;
Vendramin, Chiara ;
Liesner, Ri ;
Clark, Amanda ;
Lester, William ;
Dutt, Tina ;
Thomas, William ;
Gooding, Richard ;
Biss, Tina ;
Watson, H. G. ;
Cooper, Nichola ;
Rayment, Rachel ;
Cranfield, Tanya ;
van Veen, Joost J. ;
Hill, Quentin A. ;
Davis, Sarah ;
Motwani, Jayashree ;
Bhatnagar, Neha ;
Priddee, Nicole ;
David, Marianna ;
Crowley, Maeve P. ;
Alamelu, Jayanthi ;
Lyall, Hamish ;
Westwood, John-Paul ;
Thomas, Mari ;
Scully, Marie .
BLOOD, 2019, 133 (15) :1644-1651
[2]   ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13 [J].
Antoine, G ;
Zimmermann, K ;
Plaimauer, B ;
Grillowitzer, M ;
Studt, JD ;
Lämmle, B ;
Scheiflinger, F .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (05) :821-824
[3]   Hereditary Thrombotic Thrombocytopenic Purpura [J].
Hovinga, Johanna A. Kremer ;
George, James N. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (17) :1653-1662
[4]   Mutations and common polymorphisms in ADAMTS13 gene responsiblefor von Willebrand factor-cleaving protease activity [J].
Kokame, K ;
Matsumoto, M ;
Soejima, K ;
Yagi, H ;
Ishizashi, H ;
Funato, M ;
Tamai, H ;
Konno, M ;
Kamide, K ;
Kawano, Y ;
Miyata, T ;
Fujimura, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11902-11907
[5]   Etiologic Workup in Cases of Cryptogenic Stroke A Systematic Review of International Clinical Practice Guidelines [J].
McMahon, Naoimh E. ;
Bangee, Munirah ;
Benedetto, Valerio ;
Bray, Emma P. ;
Georgiou, Rachel F. ;
Gibson, Josephine M. E. ;
Lane, Deirdre A. ;
Al-Khalidi, A. Hakam ;
Chatterjee, Kausik ;
Chauhan, Umesh ;
Clegg, Andrew J. ;
Lightbody, C. Elizabeth ;
Lip, Gregory Y. H. ;
Sekhar, Alakendu ;
Watkins, Caroline L. .
STROKE, 2020, 51 (05) :1419-1427
[6]   Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies [J].
Plaimauer, B. ;
Hovinga, J. A. Kremer ;
Juno, C. ;
Wolfsegger, M. J. ;
Skalicky, S. ;
Schmidt, M. ;
Grillberger, L. ;
Hasslacher, M. ;
Knoebl, P. ;
Ehrlich, H. ;
Scheiflinger, F. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (05) :936-944
[7]   Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13) [J].
Plaimauer, B ;
Zimmermann, K ;
Volkel, D ;
Antoine, G ;
Kerschbaumer, R ;
Jenab, P ;
Furlan, M ;
Gerritsen, H ;
Lämmle, B ;
Schwarz, HP ;
Scheiflinger, F .
BLOOD, 2002, 100 (10) :3626-3632
[8]   von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome [J].
Remuzzi, G ;
Galbusera, M ;
Noris, M ;
Canciani, MT ;
Daina, E ;
Bresin, E ;
Contaretti, S ;
Caprioli, J ;
Gamba, S ;
Ruggenenti, P ;
Perico, N ;
Mannucci, PM .
BLOOD, 2002, 100 (03) :778-785
[9]   Current prophylactic plasma infusion protocols do not adequately prevent long-term cumulative organ damage in the Japanese congenital thrombotic thrombocytopenic purpura cohort [J].
Sakai, Kazuya ;
Fujimura, Yoshihiro ;
Miyata, Toshiyuki ;
Isonishi, Ayami ;
Kokame, Koichi ;
Matsumoto, Masanori .
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 194 (02) :444-452
[10]   Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura [J].
Scully, Marie ;
Knoebl, Paul ;
Kentouche, Karim ;
Rice, Lawrence ;
Windyga, Jerzy ;
Schneppenheim, Reinhard ;
Hovinga, Johanna A. Kremer ;
Kajiwara, Michiko ;
Fujimura, Yoshihiro ;
Maggiore, Caterina ;
Doralt, Jennifer ;
Hibbard, Christopher ;
Martell, Leah ;
Ewenstein, Bruce .
BLOOD, 2017, 130 (19) :2055-2063